Viewing Study NCT05904093

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:02 AM
Ignite Modification Date: 2026-02-02 @ 11:23 AM
Study NCT ID: NCT05904093
Status: RECRUITING
Last Update Posted: 2025-09-15
First Post: 2023-06-13
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sickle Cell Disease View
None Hb-SS Disease View
None Hemoglobin S View
None Disease Sickle Cell Anemia View
None Sickle Cell Disorders View
None Hemoglobin Beta Thalassemia Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Sickle Cell View
None Tyrosine Kinase Inhibitor View
None Fostamatinib View